What's new

Human medicines European public assessment report (EPAR): Aucatzyl, obecabtagene autoleucel, Status: Opinion

Human medicines European public assessment report (EPAR): Aucatzyl, obecabtagene autoleucel, Status: Opinion

May 23, 2025 - 12:15
 0
Human medicines European public assessment report (EPAR): Aucatzyl, obecabtagene autoleucel, Status: Opinion
Human medicines European public assessment report (EPAR): Aucatzyl, obecabtagene autoleucel, Status: Opinion
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Itovebi, inavolisib, S...

Next Article

Human medicines European public assessment report (EPAR): Riulvy, tegomil fumara...

Related Posts

Human medicines European public assessment report (EPAR): Maapliv, amino acids, Status: Opinion

Human medicines European public assessment report (EPAR...

May 23, 2025  0

European Society of Cardiology (ESC) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 May 2025, 15:00 (CEST) to 22 May 2025, 17:00 (CEST)

European Society of Cardiology (ESC) bilateral meeting,...

May 21, 2025  0

Human medicines European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Date of authorisation: 01/12/2008, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0